Improving Cancer Outcomes

Cancer research advances drive significant mortality improvements, changing how cancers are defined, prevented, diagnosed, and treated. ​

AI-driven prevention efforts improve cancer risk prediction, allowing for better risk reduction and more accurate underwriting assessment while requiring the need to monitor potential anti-selective behavior.

AI-fueled diagnostic advances and liquid biopsies enable earlier cancer detection and improved risk stratification, requiring updates to product definitions and cancer classification. ​

Personalized therapies, including targeted drug development and immunotherapies, continue to evolve, with potentially significant impact on outcomes – and on healthcare costs.